Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 48 out of 100. Prevention and risk

Topic: Risk, prevention and care in population studies

Plain-language summary

The 12 risk factors account for 60.3% of dementia cases in China, including 14.0% in early life, 8.8% in midlife, and 37.5% in later life. Some factors (e.g., alcohol abuse, depression) showed wide confidence intervals indicating lack of evidence. This study highlights the potential for dementia prevention in China, but more evidence is needed to estimate PAFs for specific risk factors (e.g., midlife factors). HIGHLIGHTS: We used the most recent and nationally representative data to calculate population attributable fractions (PAFs) for dementia risk factors in China. In China, 60.3% of dementia cases were attributed to the 12 modifiable risk factors. Education was estimated to contribute 14.0% of dementia cases, and 37.5% was attributed to later-life lifestyle and health factors in China. It is necessary to consider incorporating China-specific factors and updating the PAF calculation method.

What this study adds

Evidence grade: Moderate

This is a follow-up (cohort) study. This analysis estimates that 12 modifiable risk factors account for 60.3% of dementia cases in China, with 14.0% in early life, 8.8% in midlife, and 37.5% in later life. Reported effect size: or 60.3; 14.0%; 8.8%.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Zhou, Y., Liao, J., & Wu, Y. (2025). Dementia risk reduction in China: Country‐specific estimates of modifiable risk factors and population attributable fractions (PAFs). Alzheimer s & Dementia. https://doi.org/10.1002/alz.70542

Vancouver

Zhou Y, Liao J, Wu Y. Dementia risk reduction in China: Country‐specific estimates of modifiable risk factors and population attributable fractions (PAFs). Alzheimer s & Dementia. 2025. doi:10.1002/alz.70542. PMID: 40879658.

BibTeX

@article{zhou2025-40879658,
  author  = {Zhou, Yujing and Liao, Jing and Wu, Yu‐Tzu},
  title   = {{Dementia risk reduction in China: Country‐specific estimates of modifiable risk factors and population attributable fractions (PAFs)}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz.70542},
  pmid    = {40879658},
  url     = {https://doi.org/10.1002/alz.70542}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

This analysis estimates that 12 modifiable risk factors account for 60.3% of dementia cases in China, with 14.0% in early life, 8.8% in midlife, and 37.5% in later life. The authors note that some factors had wide confidence intervals indicating lack of evidence, and that more evidence is needed for specific risk factors.

Study details

How this study scored 48/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 7 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 2 of 3; Studied in people 0 of 3; Randomized / blinded 0 of 2; Times cited 1 of 7; Citations per year 1 of 5; Impact for its field and year 2 of 6; Cited by studies here 0 of 6; Still being cited 1 of 4; Senior author's track record 2 of 4; Institution's track record 1 of 3; Multicenter collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 48 of 100.48 of 100 points earned52 not earned

Published in a peer-reviewed journal, and it is a longitudinal study following the same people over time. Scored zero for sample size, studied in people and randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Alzheimer s & Dementia)
Journal's citation record 2 / 4 Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29)
Study design 7 / 12 A longitudinal study following the same people over time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 4 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 1.3 citations a year over 3 year(s) since 2025
Impact for its field and year 2 / 6 Cited 2.5× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 1 / 4 Cited 4 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Yu‐Tzu Wu: h-index 41 (OpenAlex, whole career)
Institution's track record 1 / 3 Newcastle University: institution h-index 932 (OpenAlex)
Multicenter collaboration 1 / 3 OpenAlex lists 2 institution(s) in 2 countries
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 40879658)
Free to read 2 / 2 Free to read
Total 48 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 16.

Related studies in Prevention and risk from nearby years

Also tagged “biobank”

1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Prevention and risk

See all studies in Prevention and risk →